v3.23.3
Condensed Consolidated Statements of Cash Flows - USD ($)
$ in Thousands
9 Months Ended
Sep. 30, 2023
Sep. 30, 2022
Cash flow from operating activities:    
Net loss $ (7,097) $ (10,415)
Adjustments to reconcile net loss to net cash used in operating activities:    
Depreciation 122 151
Stock-based compensation expense 531 318
Issuance of common stock to vendor 55 230
Right-of-use asset amortization 197 197
Gain/(loss) on foreign currency transactions (66) 3,131
Transaction costs allocable to warrant liability 198  
Warrant liability fair value adjustment (461)  
Change in operating assets and liabilities:    
Accounts receivable (24) (21)
Research and development tax credit receivable 697 104
Prepaid expenses and other current assets (159) (311)
Accounts payable and accrued expenses 713 (29)
Lease liabilities (201) (190)
Income tax payable (23)  
Other current liabilities (102)  
Net cash used in operating activities (5,620) (6,835)
Cash flows from investing activities:    
Purchases of property, plant and equipment (12) (67)
Net cash used by investing activities (12) (67)
Cash flow from financing activities:    
Proceeds from the issuance of preferred stock in private placement 12,386  
Proceeds from the issuance of warrants in private placement 1,763  
Proceeds from the issuance of common stock in private placement   2,000
Payment of issuance costs (1,483) (170)
Proceeds from the exercise of warrants 25  
Net cash provided by financing activities 12,691 1,830
Effect of exchange rate changes on cash (84) (850)
Net change in cash 6,975 (5,922)
Cash, beginning of period 4,235 12,226
Cash, end of period 11,210 6,304
Supplemental disclosure of cash and non-cash investing and financing activities    
Initial classification of fair value of warrants 1,837  
Right-of-use asset and lease liability additions $ 50 $ 583

Source